Original Research
Published on 29 Jul 2025
CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 340 views